Skip to Main Content

Paper Details

A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat.
Acta Neuropathol
69
2011
C ependymoma, DKFZ-EP1NS, DKFZ-EP1NS cells, HDACi, Vorinostat, cisplatin, ependymoma, ependymoma tumor, ependymomas, high-, histone deacetylase, human, human cell line, human high-risk ependymoma stem cell model, neural stem cell, patient, primary, primary ependymoma cells, secondary, stem cell, temozolomide, tumor, tumors, vincristine, xenografts
Author NameAffiliation
Till MildeClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center
  • 1 - 1

Datasets

Release 1.2